The Bulletin
The Times


.

Albatroz Therapeutics Soars into Johnson Johnson Innovation - JLABS Singapore

  • Written by PR Newswire

SINGAPORE, Sept. 3, 2024 /PRNewswire/ -- Albatroz Therapeutics, a biotechnology company developing novel therapies against cancer and other indications, today announced its membership of Johnson & Johnson Innovation – JLABS Singapore.

"We are thrilled to join the vibrant life science community at JLABS," said Dr. Frederic Bard, CEO of...

hacklink esim balkanzlibraryzlibrarySahabetuk casinos not on gamstopGamStopgrandpashabet girişviagra 100 mg fiyattaraftarium24taraftarium24extrabet